Priority Date: 31.01.12 (US 201261593019P)

DIRECT DETECTION OF DISEASE BIOMARKERS IN CLINICAL SPECIMENS USING CATIONIC NANOPARTICLE-BASED ASSAYS&VERSATILE AND GREEN METHODS FORSYNTHESIS OF ANISOTROPIC SILVER NANOSTRUCTURES

  • Application ID: EP13742955
  • Status: GRANT OF PATENT INTENDED

Applicant

Research organisation logo small
Research Organisation

Attorney

Company dna brevalex
no operation time available
1204.46
3 offices
active in Legal Services

Specialization

This EP application has the IPC combination C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) and G01 (MEASURING; TESTING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Weidner Stern Jeschke, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd and 98 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 31.01.2012 - Priority Date (US 201261593019P)
  • 08.08.2013 - Publication A2 (WO2013116513)
  • 10.12.2014 - Publication A2 (EP2810067)